Perspectives in Nanomedicine-Based Research Towards Cancer Therapies | Bentham Science
Generic placeholder image

Current Nanoscience

Editor-in-Chief

ISSN (Print): 1573-4137
ISSN (Online): 1875-6786

Perspectives in Nanomedicine-Based Research Towards Cancer Therapies

Author(s): Yogesh M. Rane and Eliana B. Souto

Volume 7, Issue 2, 2011

Page: [142 - 152] Pages: 11

DOI: 10.2174/157341311794653640

Price: $65

Open Access Journals Promotions 2
Abstract

Nanomedicine is focused on the development of submicrometer carriers designed for improving the biodistribution of systemically administered drugs. Nanoparticles have been exploited for immunoassays, immunohistochemistry, cancer diagnostics, bioseparation of specific cell populations, and cellular imaging. Public awareness on the use of these novel therapeutic approaches is increasing due to the exponential boom of nanotechnologies in the latest years. With respect to cancer therapy, several tumour-targeted nanomedicines have been evaluated over the years, and there is a clear evidence for substantial improvement of the therapeutic index of antineoplastics. The present review addresses the most relevant targeting strategies, discussing the major public awareness, therapeutic advances and future directions in the development of tumour-targeted nanomedicines.

Keywords: Nanotechnology, Nanomedicine, Cancer, Gene therapy, Anti-neoplastic drugs, Cancer diagnosis, Public health, Nanoparticles, Molecular imaging, nanocrystal fluorophores

Next »

Rights & Permissions Print Cite
© 2024 Bentham Science Publishers | Privacy Policy